BRIEF published on 03/01/2024 at 18:18, 6 months 19 days ago Volker Brielmann nommé nouveau PDG d'Adval Tech Group Changement De Direction Volker Brielmann Technologie Adval Nomination Du PDG Innovation Manufacturière
PRESS RELEASE published on 03/01/2024 at 18:13, 6 months 19 days ago Volker Brielmann to become new CEO of the Adval Tech Group Volker Brielmann appointed as new CEO of the Adval Tech Group. Adval Tech Management AG releases ad hoc announcement Ad Hoc Announcement CEO Volker Brielmann Adval Tech Management AG Art. 53 LR
PRESS RELEASE published on 08/25/2023 at 07:00, 1 year ago Adval Tech Group stabilizes total income under difficult conditions
PRESS RELEASE published on 05/11/2023 at 18:00, 1 year 4 months ago Annual General Meeting 2023: Adval Tech shareholders approved all proposals
PRESS RELEASE published on 04/03/2023 at 07:00, 1 year 5 months ago Adval Tech increases total income despite massive disruptions in global supply chains
Published on 09/20/2024 at 23:40, 2 hours 11 minutes ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 2 hours 21 minutes ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 23:00, 2 hours 51 minutes ago AI/ML Innovations Inc. Provides Second Status Update
Published on 09/20/2024 at 22:30, 3 hours 21 minutes ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 3 hours 36 minutes ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/20/2024 at 22:58, 2 hours 52 minutes ago Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Published on 09/20/2024 at 21:00, 4 hours 51 minutes ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 20:14, 5 hours 36 minutes ago EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Published on 09/20/2024 at 19:50, 6 hours 1 minute ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 19:47, 6 hours 4 minutes ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Published on 09/20/2024 at 17:40, 8 hours 11 minutes ago Availability of the 2024 Half-Year Financial Report
Published on 09/20/2024 at 17:40, 8 hours 11 minutes ago Mise à disposition du Rapport Financier Semestriel 2024